I now have ample additional material. Here are the additional one-mark questions:
Additional One-Mark Questions: Breast Milk and Breastfeeding
(Continuing from Q53 - Sources: Histology Text & Atlas, Swanson's Family Medicine Review, Tintinalli's Emergency Medicine, Costanzo Physiology, Red Book AAP, Park's PSM)
SECTION I: Colostrum
Q54. What is the color and reaction (pH) of colostrum?
Ans. Yellowish in color; alkaline in reaction
Q55. What is colostrum often called in terms of its role before true milk appears?
Ans. "Premilk" - the secretion released in the first few days after childbirth before true lipid-rich milk is produced
Q56. Compared to mature breast milk, colostrum has higher content of which four components?
Ans. Higher protein, Vitamin A, sodium, and chloride
Q57. Compared to mature breast milk, colostrum has lower content of which three components?
Ans. Lower lipid, carbohydrate, and potassium
Q58. More than half of the protein content of colostrum consumed by breastfeeding neonates consists of which immunoglobulin?
Ans. IgA (secretory IgA)
Q59. Name the immunomodulating agents supplied by colostrum (beyond antibodies).
Ans. Complement, lysozyme, lactoferrin, cytokines, and interleukins
Q60. Which cells present in colostrum provide passive immunity to the newborn?
Ans. Macrophages and lymphocytes (which produce secretory IgA antibodies)
Q61. What happens to the production of colostrum after parturition?
Ans. As the lymphocytes and plasma cells (that produce colostral antibodies) decrease in number after delivery, colostrum production stops and lipid-rich milk begins
SECTION B - Extended: Physiology of Milk Production
Q62. Which hormone stimulates lactogenesis (milk production)?
Ans. Prolactin (from the anterior pituitary)
Q63. Which hormone is responsible for milk letdown (milk ejection)?
Ans. Oxytocin (from the posterior pituitary)
Q64. What is the mechanism of milk letdown by oxytocin?
Ans. Oxytocin causes contraction of myoepithelial cells lining small milk ducts, forcing milk into large ducts - it then collects in cisterns and flows out through the nipple
Q65. What stimulates the secretion of oxytocin during breastfeeding?
Ans. Suckling (and conditioned responses)
Q66. In which part of the breast are alveolar cells that secrete milk located?
Ans. In the alveoli (acini) of the mammary gland
Q67. The lipid (fatty) component of milk is secreted by which type of secretion?
Ans. Apocrine secretion (lipid droplets are released with an envelope of plasma membrane)
Q68. Which hormones are responsible for the massive increase in terminal duct lobular units (TDLUs) during pregnancy to prepare for lactation?
Ans. Estrogens and progesterone (from corpus luteum and placenta), plus prolactin, human chorionic somatomammotropin (hCS), and adrenal glucocorticoids
SECTION J: Breast Milk Jaundice
Q69. What is the mechanism of breast milk jaundice?
Ans. Substances in breast milk inhibit glucuronyl transferase (bilirubin conjugating enzyme), leading to accumulation of unconjugated bilirubin
Q70. When does breast milk jaundice typically start, and when does it peak?
Ans. It may start as early as the 3rd to 4th day; it peaks at 10 to 27 mg/dL by the third week of life
Q71. Is breast milk jaundice likely to cause kernicterus?
Ans. No - breast milk jaundice is unlikely to cause kernicterus
Q72. What is the recommended treatment when breast milk jaundice reaches significant levels?
Ans. Phototherapy (when necessary); cessation of breastfeeding will cause rapid decline of bilirubin in 2-3 days but is NOT routinely recommended
Q73. Distinguish breast milk jaundice from breastfeeding jaundice (starvation jaundice).
Ans. Breast milk jaundice is due to inhibition of glucuronyl transferase by a substance in milk (appears at day 3-4, peaks at 3 weeks). Breastfeeding/starvation jaundice occurs when milk supply is inadequate - poor intake leads to reduced stool output and bilirubin excretion, accentuating physiologic jaundice
Q74. How does phototherapy work to treat hyperbilirubinemia?
Ans. It causes a configurational change in the bilirubin structure, allowing it to be excreted in the urine without conjugation
SECTION K: Mastitis and Breast Complications
Q75. What proportion of breastfeeding women in the USA develop postpartum mastitis?
Ans. One-third (33%) of breastfeeding women
Q76. What percentage of mastitis cases progress to breast abscess?
Ans. Up to 10% of mastitis cases
Q77. What pathogens are most commonly associated with mastitis and contaminated expressed human milk?
Ans. Staphylococcus species and gram-negative bacilli
Q78. In a case of breast abscess with a drain in place, should breastfeeding on the affected breast be continued?
Ans. Yes - breastfeeding on the affected breast should continue as long as the infant's mouth is not in direct contact with purulent drainage or infected tissue
Q79. In infectious mastitis, what is the general recommendation regarding continuation of breastfeeding?
Ans. Breastfeeding on the affected side is generally recommended and should continue during appropriate antimicrobial therapy; breastfeeding may continue on the unaffected breast even when interrupted on the affected breast
SECTION L: Tuberculosis and Breastfeeding
Q80. When can a mother with tuberculosis safely breastfeed?
Ans. When she has been appropriately treated for 2 or more weeks AND is no longer considered contagious (negative sputum smear)
Q81. If a mother with TB is still considered contagious, what is advised?
Ans. She should refrain from breastfeeding and from close contact with the infant (risk of airborne/droplet spread of TB), but expressed human milk can still be fed to the infant (as long as there is no TB mastitis)
Q82. Is tuberculosis mastitis common?
Ans. No - tuberculosis mastitis is rare
SECTION M: Rotavirus Vaccine and Breastfeeding
Q83. Does breastfeeding interfere with the effectiveness of rotavirus vaccine?
Ans. No - in licensing trials, the effectiveness of rotavirus vaccine in breastfed infants was comparable to non-breastfed infants; postmarketing studies showed no improved antibody response when breastfeeding was temporarily withheld before/after vaccination
Q84. What is the effect of breastfeeding on rotavirus disease in infancy?
Ans. Breastfeeding reduces the likelihood of rotavirus disease in infancy
Q85. Can high concentrations of poliovirus antibodies in human milk interfere with oral poliovirus vaccine (OPV) immunogenicity?
Ans. Theoretically yes for OPV - but this is NOT a concern with inactivated poliovirus vaccine (IPV), which is now the standard in the USA
SECTION N: Growth and Weight in Breastfed Infants
Q86. What is the minimum standard weight gain expected per day in a neonate?
Ans. 30 g/day
Q87. By what age should all infants regain their birth weight?
Ans. By 10 to 14 days of life
Q88. What are two clinical signs at the 2-week visit that indicate adequate breastfeeding?
Ans. Frequent wet diapers, frequent stools, coupled with return to birth weight
Q89. New solid foods introduced during weaning should be introduced how frequently?
Ans. One new food every 1 to 2 weeks (to monitor for allergy/intolerance)
SECTION O: Drugs and Lactation
Q90. As a general rule, what category of drugs is considered probably safe to use during breastfeeding?
Ans. Any drug that can be given safely to a neonate is probably safe to use during breastfeeding
Q91. What does the AAP publish to guide drug use during lactation?
Ans. A review of drugs and chemicals that can be safely used during lactation (updated periodically)
Q92. Despite the fact that most drugs are excreted into breast milk in amounts too small to adversely affect neonatal health, what is a common consequence for many women on medications?
Ans. Thousands of women taking medications unnecessarily choose not to breastfeed
SECTION P: Miscellaneous / High-Yield Facts
Q93. Which is the only poliovirus vaccine used in the USA currently?
Ans. Inactivated poliovirus vaccine (IPV)
Q94. What is the hierarchical preference for feeding immune-protective factors?
Ans. Freshly expressed mother's milk > refrigerated/frozen mother's milk > pasteurized donor milk
Q95. Is routine culturing or heat treatment of a mother's milk fed to her own infant recommended?
Ans. No - it has not been demonstrated to be necessary or cost-effective
Q96. Freezing human milk at -20°C for the purpose of reducing CMV infectivity - is it advised?
Ans. No - while freezing may reduce CMV viral load, it does NOT change the risk of CMV sepsis-like syndrome, and it also reduces the bioactivity of human milk
Q97. For breastfed preterm infants with a CMV-seropositive mother, what pasteurization option reduces CMV transmission while preserving milk quality?
Ans. Short-term pasteurization (72°C / 161.6°F for 5 seconds) - it appears to be less harmful to the beneficial constituents of human milk than Holder pasteurization
Q98. Which national initiative in India supports breastfeeding promotion, supported by major professional medical and nursing bodies?
Ans. Baby-Friendly Hospital Initiative (BFHI), under WHO and UNICEF
Q99. According to BFHI Step 4, what should be facilitated immediately after birth?
Ans. Immediate and uninterrupted skin-to-skin contact, supporting mothers to initiate breastfeeding as soon as possible after birth
Q100. Powdered bovine colostrum (as a nutritional supplement) has been shown to improve outcomes in children under 2 with diarrhoea caused by which pathogens?
Ans. Rotavirus and enteric E. coli
Total: 100 one-mark questions across composition, colostrum, physiology of lactation, advantages, breastfeeding practices, BFHI, contraindications, virus transmission (CMV, Ebola, HIV, HBV), immunization, jaundice (breast milk vs. breastfeeding jaundice), mastitis, TB, drugs in lactation, rotavirus vaccine, and infant growth monitoring.